SNAP-25 Fragment vs SNAP-8
A side-by-side research comparison of SNAP-25 Fragment and SNAP-8 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | SNAP-25 Fragment | SNAP-8 |
|---|---|---|
| Full name | SNAP-25 Inhibitory Fragment Peptide | SNAP-8 (Acetyl Octapeptide-3) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Directly competes with the SNAP-25 binding domain in SNARE complex formation, providing highly specific inhibition of vesicle fusion at facial neuromuscular junctions. | More effectively competes with SNAP-25 for SNARE complex incorporation due to longer sequence, providing greater vesicle-membrane fusion inhibition. |
| Molecular weight | ~650 Da | 1,075 Da |
| Half-life | N/A (topical depot) | 8-14 hours (topical) |
| Bioavailability | Topical penetration ~6-9% | Moderate (topical) |
| Typical dose | 3-8% in formulation | 3-10% solution |
| Frequency | 2x daily | 2x daily |
| Route | Topical serum | Topical |
SNAP-25 Fragment reported benefits
- Highly specific SNARE targeting
- Expression line reduction
- Improved selectivity
- Complementary to Argireline
SNAP-8 reported benefits
- Superior to argireline
- Deeper wrinkle reduction
- Prevents expression lines
- Good skin penetration
Related comparisons
Research and educational reference only. Not medical advice.